These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34699840)

  • 1. Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies.
    Segués A; van Duijnhoven SMJ; Parade M; Driessen L; Vukovic N; Zaiss D; Sijts AJAM; Berraondo P; van Elsas A
    J Immunol Methods; 2021 Dec; 499():113173. PubMed ID: 34699840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity.
    Chen Y; Jia M; Wang S; Xu S; He N
    Front Immunol; 2022; 13():835690. PubMed ID: 35251028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated targeting of TNFR2 activates CD8
    Tam EM; Fulton RB; Sampson JF; Muda M; Camblin A; Richards J; Koshkaryev A; Tang J; Kurella V; Jiao Y; Xu L; Zhang K; Kohli N; Luus L; Hutto E; Kumar S; Lulo J; Paragas V; Wong C; Suchy J; Grabow S; Dugast AS; Zhang H; Depis F; Feau S; Jakubowski A; Qiao W; Craig G; Razlog M; Qiu J; Zhou Y; Marks JD; Croft M; Drummond DC; Raue A
    Sci Transl Med; 2019 Oct; 11(512):. PubMed ID: 31578241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.
    Jiang M; Liu J; Yang D; Tross D; Li P; Chen F; Alam MM; Faustman DL; Oppenheim JJ; Chen X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108345. PubMed ID: 34794079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability
    Urbano PCM; Koenen HJPM; Joosten I; He X
    Front Immunol; 2018; 9():573. PubMed ID: 29619032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism.
    Anany MA; Haack S; Lang I; Dahlhoff J; Vargas JG; Steinfatt T; Päckert L; Weisenberger D; Zaitseva O; Medler J; Kucka K; Zhang T; Van Belle T; van Rompaey L; Beilhack A; Wajant H
    Theranostics; 2024; 14(2):496-509. PubMed ID: 38169605
    [No Abstract]   [Full Text] [Related]  

  • 7. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
    Twu YC; Gold MR; Teh HS
    Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel TNFR2 agonist antibody expands highly potent regulatory T cells.
    Torrey H; Kühtreiber WM; Okubo Y; Tran L; Case K; Zheng H; Vanamee E; Faustman DL
    Sci Signal; 2020 Dec; 13(661):. PubMed ID: 33293464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.
    Punit S; Dubé PE; Liu CY; Girish N; Washington MK; Polk DB
    Gastroenterology; 2015 Oct; 149(4):993-1005.e2. PubMed ID: 26072395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
    Torrey H; Butterworth J; Mera T; Okubo Y; Wang L; Baum D; Defusco A; Plager S; Warden S; Huang D; Vanamee E; Foster R; Faustman DL
    Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.
    Nie Y; He J; Shirota H; Trivett AL; Yang D; Klinman DM; Oppenheim JJ; Chen X
    Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect.
    Naserian S; Abdelgawad ME; Afshar Bakshloo M; Ha G; Arouche N; Cohen JL; Salomon BL; Uzan G
    Cell Commun Signal; 2020 Jun; 18(1):94. PubMed ID: 32546175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a TNFR2-Selective Agonistic TNF-α Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander.
    Inoue M; Yamashita K; Tsuji Y; Miki M; Amano S; Okumura T; Kuge K; Tone T; Enomoto S; Yoshimine C; Morita Y; Ando D; Kamada H; Mikami N; Tsutsumi Y; Tsunoda SI
    J Immunol; 2021 Apr; 206(8):1740-1751. PubMed ID: 33782090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.
    Yang S; Wang J; Brand DD; Zheng SG
    Front Immunol; 2018; 9():784. PubMed ID: 29725328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models.
    Case K; Tran L; Yang M; Zheng H; Kuhtreiber WM; Faustman DL
    J Leukoc Biol; 2020 Jun; 107(6):981-991. PubMed ID: 32449229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.
    Joedicke JJ; Myers L; Carmody AB; Messer RJ; Wajant H; Lang KS; Lang PA; Mak TW; Hasenkrug KJ; Dittmer U
    J Immunol; 2014 Sep; 193(6):2952-60. PubMed ID: 25098294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes.
    Fischer R; Sendetski M; Del Rivero T; Martinez GF; Bracchi-Ricard V; Swanson KA; Pruzinsky EK; Delguercio N; Rosalino MJ; Padutsch T; Kontermann RE; Pfizenmaier K; Bethea JR
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):17045-17050. PubMed ID: 31391309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFR1 and TNFR2 signaling interplay in cardiac myocytes.
    Defer N; Azroyan A; Pecker F; Pavoine C
    J Biol Chem; 2007 Dec; 282(49):35564-73. PubMed ID: 17913704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.
    Williams GS; Mistry B; Guillard S; Ulrichsen JC; Sandercock AM; Wang J; González-Muñoz A; Parmentier J; Black C; Soden J; Freeth J; Jovanović J; Leyland R; Al-Lamki RS; Leishman AJ; Rust SJ; Stewart R; Jermutus L; Bradley JR; Bedian V; Valge-Archer V; Minter R; Wilkinson RW
    Oncotarget; 2016 Oct; 7(42):68278-68291. PubMed ID: 27626702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.